Equities

Voyageur Pharmaceuticals Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
VM:CVE

Voyageur Pharmaceuticals Ltd

Actions
  • Price (CAD)0.145
  • Today's Change0.005 / 3.57%
  • Shares traded28.18k
  • 1 Year change-19.44%
  • Beta0.0296
Data delayed at least 15 minutes, as of Feb 17 2026 15:14 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Cash flow in CADView more

In 2024, Voyageur Pharmaceuticals Ltd increased its cash reserves by 7,822.01%, or 163.48k. Cash Flow from Financing totalled 631.73k or -- of revenues. In addition the company used 302.29k for operations while cash used for investing totalled 165.96k.
Cash flow per share-0.02
Price/Cash flow per share--
Book value per share0.0081
Tangible book value per share0.0081
More ▼

Balance sheet in CADView more

Voyageur Pharmaceuticals Ltd uses little debt in its capital structure as supported by a debt to capital ratio of 2.70%.
Current ratio0.5782
Quick ratio0.5081
Total debt/total equity0.0277
Total debt/total capital0.027
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.